Aleksey V. Sotnikov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aleksey V. Sotnikov has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Александр Волеславович Гордиенко
Federal state budgetary military educational institution of high education “Military medical academy named after S. M. Kirov” of Russian Ministry of defense, Saint-Petersburg, Russian Federation
21 shared publications - Evgeny Vladimirovich Kryukov
Military Medical Academy
9 shared publications - Valery T. Sakhin
National Medical Research Center for High Medical Technologies — A.A. Vishnevsky Central Military Clinical Hospital of the Ministry of Defense of Russia
9 shared publications - Дмитрий Владимирович Носович
S.M. Kirov Military Medical Academy
9 shared publications - Oleg A. Rukavitsyn
Main Military Clinical Hospital named after academician N.N. Burdenko of the Ministry of Defense of the Russia
8 shared publications - Sergey P. Kazakov
Main Military Clinical Hospital named after academician N.N. Burdenko Russian Defense Ministry, Moscow, Russia; Academy of Postgraduate Education of the Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies, FMBA of Russia, Moscow, Russia
8 shared publications
Latest Publications
- 8 June 2025
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 103 (2) , 120-128
Hepcidin and the soluble transferrin receptor: significance in the pathogenesis and diagnosis of anemia of chronic diseases in patients with HIV infections
Anemia of chronic disease (ACD) in patients with human immunodeficiency virus (HIV) is a common complication that reduces quality of life and worsens prognosis. The study of hepcidin and soluble transferrin receptor (sTfR) in the pathogenesis and diagnosis of ACD remains relevant. The aim of the study was to compare the secretion of hepcidin and sTfR in patients with HIV infection who developed ACD, iron deficiency anemia (IDA), and their combination. We assessed their impact on erythrocytes and hemoglobin and determined their diagnostic significance in the differential diagnosis of ACD and IDA. Material and methods. A total of 125 HIV-infected patients were examined, who were divided into ACD, ACD/IDA, IDA, and a control group without anemia based on the criteria of Van Santen and Worwood. Patients in all groups were comparable in age and sex. Results. Comparative analysis showed that in the IDA group, the concentration of hepcidin was minimal and sTfR was maximal. In the ACD group, the concentration of sTfR did not differ from the control group, while the concentration of hepcidin was lower than that in the control group. In the ACD group, a moderate correlation was found between hepcidin, sTfR, erythrocytes, and hemoglobin. Their diagnostic significance for the differential diagnosis of ACD and IDA was found to be low. Conclusion. The study established a minor role for hepcidin and sTfR in the development of ACD in HIV patients and their low diagnostic significance for the differential diagnosis of ACD and IDA, which is significantly lower than that of ferritin. Further research into the pathogenesis of ACD in HIV-infected patients is needed.
- 8 June 2025
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 103 (2) , 120-128
Hepcidin and the soluble transferrin receptor: significance in the pathogenesis and diagnosis of anemia of chronic diseases in patients with HIV infections
Anemia of chronic disease (ACD) in patients with human immunodeficiency virus (HIV) is a common complication that reduces quality of life and worsens prognosis. The study of hepcidin and soluble transferrin receptor (sTfR) in the pathogenesis and diagnosis of ACD remains relevant. The aim of the study was to compare the secretion of hepcidin and sTfR in patients with HIV infection who developed ACD, iron deficiency anemia (IDA), and their combination. We assessed their impact on erythrocytes and hemoglobin and determined their diagnostic significance in the differential diagnosis of ACD and IDA. Material and methods. A total of 125 HIV-infected patients were examined, who were divided into ACD, ACD/IDA, IDA, and a control group without anemia based on the criteria of Van Santen and Worwood. Patients in all groups were comparable in age and sex. Results. Comparative analysis showed that in the IDA group, the concentration of hepcidin was minimal and sTfR was maximal. In the ACD group, the concentration of sTfR did not differ from the control group, while the concentration of hepcidin was lower than that in the control group. In the ACD group, a moderate correlation was found between hepcidin, sTfR, erythrocytes, and hemoglobin. Their diagnostic significance for the differential diagnosis of ACD and IDA was found to be low. Conclusion. The study established a minor role for hepcidin and sTfR in the development of ACD in HIV patients and their low diagnostic significance for the differential diagnosis of ACD and IDA, which is significantly lower than that of ferritin. Further research into the pathogenesis of ACD in HIV-infected patients is needed.
- Open Access
- 22 January 2025
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 23 (4) , 74-81
Predictors of pulmonary hypertension in the subacute period of myocardial infarction in young and middle-aged males
Aim. To identify predictors of the development of pulmonary hypertension (PH) in the subacute period of myocardial infarction (MI) in young and middle-aged males to improve preventive measures.Materials and methods. We studied the results of treatment of male patients aged 32–60 years with a verified diagnosis of MI. Based on echocardiography findings and detection of PH at the end of the third week of MI, the patients were divided into the study group (patients with PH) and the comparison group (patients with a normal pressure in the pulmonary artery). In the studied groups, a comparative assessment of various parameters was performed, and an analysis of the risks of developing PH using the Pearson’s chi-squared test was conducted.Results. We found that the risk of developing PH in the subacute period of MI was significantly affected by certain parameters of peripheral hemodynamics, the presence of bradycardia, and the calculated value of total pulmonary resistance. The main parameters of the lipid profile were found to be significant predictors of PH in the subacute period of MI, along with some parameters of electrolyte metabolism (sodium and magnesium in the first 48 hours of MI, potassium and calcium at the end of the third week of the disease). We established the presence of a reliable relationship between several parameters of the structural and functional state of the myocardium both in the first 48 hours of MI and the end of the third week of the disease with the risk of developing PH in the subacute period of MI.Conclusion. The identified predictors make it possible to determine patients with MI who are at an increased risk of PH to timely diagnose and treat the disease and improve the prognosis.
- 22 January 2025
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 23 (4) , 74-81
Open AccessPredictors of pulmonary hypertension in the subacute period of myocardial infarction in young and middle-aged males
Aim. To identify predictors of the development of pulmonary hypertension (PH) in the subacute period of myocardial infarction (MI) in young and middle-aged males to improve preventive measures.Materials and methods. We studied the results of treatment of male patients aged 32–60 years with a verified diagnosis of MI. Based on echocardiography findings and detection of PH at the end of the third week of MI, the patients were divided into the study group (patients with PH) and the comparison group (patients with a normal pressure in the pulmonary artery). In the studied groups, a comparative assessment of various parameters was performed, and an analysis of the risks of developing PH using the Pearson’s chi-squared test was conducted.Results. We found that the risk of developing PH in the subacute period of MI was significantly affected by certain parameters of peripheral hemodynamics, the presence of bradycardia, and the calculated value of total pulmonary resistance. The main parameters of the lipid profile were found to be significant predictors of PH in the subacute period of MI, along with some parameters of electrolyte metabolism (sodium and magnesium in the first 48 hours of MI, potassium and calcium at the end of the third week of the disease). We established the presence of a reliable relationship between several parameters of the structural and functional state of the myocardium both in the first 48 hours of MI and the end of the third week of the disease with the risk of developing PH in the subacute period of MI.Conclusion. The identified predictors make it possible to determine patients with MI who are at an increased risk of PH to timely diagnose and treat the disease and improve the prognosis.
- Open Access
- 17 December 2024
- Published by ECO-Vector LLC in Bulletin of the Russian Military Medical Academy
- Vol. 26 (4) , 513-522
Modern differential diagnosis of various types of anemia in patients with HIV-associated disease
This article substantiates the development of a diagnostic algorithm to differentiate between anemia of chronic disease (ACD) and iron deficiency anemia (IDA) in patients with HIV-associated disease. A cross-sectional descriptive study included 125 patients with HIV-associated disease, 101 of whom had anemia syndrome and 24 were without it (control group). Patients with anemia were divided into three groups: Group 1 with ACD only, Group 2 with ACD and IDA, and Group 3 with IDA only. Upon admission, all patients underwent assessments for red blood cell count, hemoglobin, IL-6, IL-10, and IL-1β, IFN-γ, TNF-α, ferritin, C-reactive protein, transferrin, hepcidin, and soluble transferrin receptor levels. Discriminant analysis followed by obtaining a canonical linear discriminant function was used to calculate a mathematical model for the differential diagnosis of ACD and IDA. Canonical analysis was also used to obtain centroids for ACD (2.86 arbitrary units) and IDA (2.54 arbitrary units). A patient with a calculated canonical linear discriminant function was to be assigned to the group of ACD or IDA based on the minimal distance to the corresponding centroid. The resulting mathematical model has 88.8% sensitivity and 100% specificity. The use of IL-6 and ferritin concentrations is also proposed as independent laboratory markers for the differential diagnosis of ACD and IDA. The canonical linear discriminant function obtained from the calculations, along with the levels of IL-6 and ferritin in the blood, have high diagnostic value for verifying ACD and IDA in patients with HIV-related disease. Their use enables the determination of the type of anemia during the initial contact between the physician and the patient.
- 17 December 2024
- Published by ECO-Vector LLC in Bulletin of the Russian Military Medical Academy
- Vol. 26 (4) , 513-522
Open AccessModern differential diagnosis of various types of anemia in patients with HIV-associated disease
This article substantiates the development of a diagnostic algorithm to differentiate between anemia of chronic disease (ACD) and iron deficiency anemia (IDA) in patients with HIV-associated disease. A cross-sectional descriptive study included 125 patients with HIV-associated disease, 101 of whom had anemia syndrome and 24 were without it (control group). Patients with anemia were divided into three groups: Group 1 with ACD only, Group 2 with ACD and IDA, and Group 3 with IDA only. Upon admission, all patients underwent assessments for red blood cell count, hemoglobin, IL-6, IL-10, and IL-1β, IFN-γ, TNF-α, ferritin, C-reactive protein, transferrin, hepcidin, and soluble transferrin receptor levels. Discriminant analysis followed by obtaining a canonical linear discriminant function was used to calculate a mathematical model for the differential diagnosis of ACD and IDA. Canonical analysis was also used to obtain centroids for ACD (2.86 arbitrary units) and IDA (2.54 arbitrary units). A patient with a calculated canonical linear discriminant function was to be assigned to the group of ACD or IDA based on the minimal distance to the corresponding centroid. The resulting mathematical model has 88.8% sensitivity and 100% specificity. The use of IL-6 and ferritin concentrations is also proposed as independent laboratory markers for the differential diagnosis of ACD and IDA. The canonical linear discriminant function obtained from the calculations, along with the levels of IL-6 and ferritin in the blood, have high diagnostic value for verifying ACD and IDA in patients with HIV-related disease. Their use enables the determination of the type of anemia during the initial contact between the physician and the patient.
- 30 June 2024
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
MATHEMATICAL MODELLING IN THE DIFFERENTIAL DIAGNOSIS OF ANEMIA OF CHRONIC DISEASES AND IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAMMATORY JOINT DISEASES
Aim. To develop based on the indicators of clinical blood tests, some biochemical markers, iron metabolism and cytokines a mathematical model that allows with high sensitivity and specificity to conduct differential diagnosis of anemia of chronic diseases (AHD) and iron deficiency anemia (IDA) in patients with inflammatory joint diseases (rheumatoid arthritis (RA), psoriatic arthritis (PSA), ankylosing spondylitis (AS)). Material and methods. The study included 104 patients with inflammatory joint diseases and anemic syndrome (37 males/67 females, age 48.4±5.42 years old), of which 54 patients with RA, 27 patients with PSA and 23 patients with AS. The control group consisted of 22 patients with inflammatory diseases of the joints without anemia (13 males/9 females, age 47.8±3.55 years old), of which 7 patients with RA, 10 with PSA, 5 with AS. For all patients, in addition to hemogram parameters, the concentrations of interleukin-6, interleukin-10, interleukin-1β, interferon-gamma, tumor necrosis factor alpha, ferritin, C-reactive protein, hepcidin, transferrin, soluble transferrin receptor were determined. For quantitative indicators, the median, standard error of the mean, and interquartile range was calculated. The significance of differences between several unrelated groups was determined using the Kruskal-Wallis test. The calculation of a mathematical model for the differential diagnosis of ACD and IDA was carried out using discriminant analysis. Results. As a result of the study, a canonical linear discriminant function (CLDF) was obtained: CLDF = 1.612171-0.002725× Hepcidin -0.005429× Ferritin The coordinates of the centroids are calculated, for ACD it is -1.44222008, and for IDA it is 1.52705656. A patient whose CLDF value is determined based on ferritin and hepcidin concentrations should be classified into the ACD or IDA group based on the minimum distance to the corresponding centroid. The resulting mathematical model has 100% sensitivity and 80% specificity. Conclusions. The equation based on hepcidin and ferritin (obtained from the results of discriminant analysis) allows, with high sensitivity, specificity and information ability, to carry out differential diagnosis of ACD and IDA in patients with inflammatory joints diseases instantly at the stage of initial contact with the doctor. Using of the equation will make it possible to more effectively diagnose and correct these types of anemia in this pathology, including for the purpose of more effective treatment.
- 30 June 2024
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
MATHEMATICAL MODELLING IN THE DIFFERENTIAL DIAGNOSIS OF ANEMIA OF CHRONIC DISEASES AND IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAMMATORY JOINT DISEASES
Aim. To develop based on the indicators of clinical blood tests, some biochemical markers, iron metabolism and cytokines a mathematical model that allows with high sensitivity and specificity to conduct differential diagnosis of anemia of chronic diseases (AHD) and iron deficiency anemia (IDA) in patients with inflammatory joint diseases (rheumatoid arthritis (RA), psoriatic arthritis (PSA), ankylosing spondylitis (AS)). Material and methods. The study included 104 patients with inflammatory joint diseases and anemic syndrome (37 males/67 females, age 48.4±5.42 years old), of which 54 patients with RA, 27 patients with PSA and 23 patients with AS. The control group consisted of 22 patients with inflammatory diseases of the joints without anemia (13 males/9 females, age 47.8±3.55 years old), of which 7 patients with RA, 10 with PSA, 5 with AS. For all patients, in addition to hemogram parameters, the concentrations of interleukin-6, interleukin-10, interleukin-1β, interferon-gamma, tumor necrosis factor alpha, ferritin, C-reactive protein, hepcidin, transferrin, soluble transferrin receptor were determined. For quantitative indicators, the median, standard error of the mean, and interquartile range was calculated. The significance of differences between several unrelated groups was determined using the Kruskal-Wallis test. The calculation of a mathematical model for the differential diagnosis of ACD and IDA was carried out using discriminant analysis. Results. As a result of the study, a canonical linear discriminant function (CLDF) was obtained: CLDF = 1.612171-0.002725× Hepcidin -0.005429× Ferritin The coordinates of the centroids are calculated, for ACD it is -1.44222008, and for IDA it is 1.52705656. A patient whose CLDF value is determined based on ferritin and hepcidin concentrations should be classified into the ACD or IDA group based on the minimum distance to the corresponding centroid. The resulting mathematical model has 100% sensitivity and 80% specificity. Conclusions. The equation based on hepcidin and ferritin (obtained from the results of discriminant analysis) allows, with high sensitivity, specificity and information ability, to carry out differential diagnosis of ACD and IDA in patients with inflammatory joints diseases instantly at the stage of initial contact with the doctor. Using of the equation will make it possible to more effectively diagnose and correct these types of anemia in this pathology, including for the purpose of more effective treatment.
- 30 April 2024
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
STUDY OF ERYTHROPOIETIN SECRETION IN PATIENTS WITH HIV INFECTION WITH ANEMIA OF CHRONIC DISEASES, IRON DEFICIENCY ANEMIA AND A COMBINATION OF TWO TYPES OF ANEMIA
Aim. To compare the secretion of erythropoietin in patients with infection caused by human immune deficiency virus (HIV infection) with anemia of chronic diseases (ACD), iron deficiency anemia (IDA), and their combination. Material and methods. 125 patients with HIV infection were examined: 101 with anemia (55 males, 46 women, 39.4±9.6 years), 24 - a control group of patients with HIV infection without anemia (13 males, 11 women, average age 37.6± 7.37 years). In all patients, the number of red blood cells, the concentration of hemoglobin, ferritin, C-reactive protein (CRP), transferrin saturation index (TSI) and erythropoietin were examined. All patients with anemia after determining TSI, CRP, ferritin based on Van Santen and Worwood criteria were divided into three groups depending on the type of anemia: group 1 - 36 patients with ACD (19 males, 17 women, average age 41.7 ± 11, 8 years, TSI 16.9[IQR, 10.2-23.1]%, ferritin 638.7[IQR, 326-861] μg/l, CRP 54.5 [IQR, 4.8-103.3] mg/l), group 2 – 30 patients with a combination of ACD/IDA (18 males, 12 women, average age 41.2±10 years, TSI 13.2[IQR, 9.8-14]%, ferritin 156.2 [IQR, 123-235] mcg/l, CRP 5.9 [IQR, 0.5-8.2] mg/l), group 3 – 35 patients with IDA (18 males, 17 women, average age 35.4 ±7.1 years, TSI 11.1[IQR, 4.7-13.7]%, ferritin 29[IQR, 4.2-38.9] µg/l, CRP 2.9[IQR, 0.4 -1.6] mg/l). For quantitative indicators, the median (Me), standard error of the mean (m), and interquartile range (IQR) were calculated. The significance of differences between several unrelated groups was determined using the Kruskal-Wallis test. Results. In the ACD group, a lower number of red blood cells was detected (3.3(2.7-3.8)×1012/l), compared to the group of patients with IDA (3.8(3.7-4.1)×1012/l ). Also, in the group of patients with ACD, the maximum concentration of erythropoietin was detected (28.5[11.2-28.5], U/ml), significantly higher than the concentration of this indicator in the ACD/IDA groups (14[8.1-16.3], U/ml), IDA (15.8[6.2-27.4], U/ml) and patients in the control group (6.3[4.9-7.8], U/ml). Conclusions. In the present study, ACD in isolated form or in combination with IDA was diagnosed in 65.3% of patients with HIV infection and anemic syndrome. In patients with ACD, an increased concentration of erythropoietin is combined with the lowest number of red blood cells in comparison with other groups of patients with anemia (p<0.05). The results obtained indicate a compensatory increase in erythropoietin secretion in response to suppressed erythropoiesis, or to reduced sensitivity of erythropoietin receptors. Further study of the importance of erythropoietin in the pathogenesis of chronic disease in patients with HIV infection is necessary, including to improve its treatment.
- 30 April 2024
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
STUDY OF ERYTHROPOIETIN SECRETION IN PATIENTS WITH HIV INFECTION WITH ANEMIA OF CHRONIC DISEASES, IRON DEFICIENCY ANEMIA AND A COMBINATION OF TWO TYPES OF ANEMIA
Aim. To compare the secretion of erythropoietin in patients with infection caused by human immune deficiency virus (HIV infection) with anemia of chronic diseases (ACD), iron deficiency anemia (IDA), and their combination. Material and methods. 125 patients with HIV infection were examined: 101 with anemia (55 males, 46 women, 39.4±9.6 years), 24 - a control group of patients with HIV infection without anemia (13 males, 11 women, average age 37.6± 7.37 years). In all patients, the number of red blood cells, the concentration of hemoglobin, ferritin, C-reactive protein (CRP), transferrin saturation index (TSI) and erythropoietin were examined. All patients with anemia after determining TSI, CRP, ferritin based on Van Santen and Worwood criteria were divided into three groups depending on the type of anemia: group 1 - 36 patients with ACD (19 males, 17 women, average age 41.7 ± 11, 8 years, TSI 16.9[IQR, 10.2-23.1]%, ferritin 638.7[IQR, 326-861] μg/l, CRP 54.5 [IQR, 4.8-103.3] mg/l), group 2 – 30 patients with a combination of ACD/IDA (18 males, 12 women, average age 41.2±10 years, TSI 13.2[IQR, 9.8-14]%, ferritin 156.2 [IQR, 123-235] mcg/l, CRP 5.9 [IQR, 0.5-8.2] mg/l), group 3 – 35 patients with IDA (18 males, 17 women, average age 35.4 ±7.1 years, TSI 11.1[IQR, 4.7-13.7]%, ferritin 29[IQR, 4.2-38.9] µg/l, CRP 2.9[IQR, 0.4 -1.6] mg/l). For quantitative indicators, the median (Me), standard error of the mean (m), and interquartile range (IQR) were calculated. The significance of differences between several unrelated groups was determined using the Kruskal-Wallis test. Results. In the ACD group, a lower number of red blood cells was detected (3.3(2.7-3.8)×1012/l), compared to the group of patients with IDA (3.8(3.7-4.1)×1012/l ). Also, in the group of patients with ACD, the maximum concentration of erythropoietin was detected (28.5[11.2-28.5], U/ml), significantly higher than the concentration of this indicator in the ACD/IDA groups (14[8.1-16.3], U/ml), IDA (15.8[6.2-27.4], U/ml) and patients in the control group (6.3[4.9-7.8], U/ml). Conclusions. In the present study, ACD in isolated form or in combination with IDA was diagnosed in 65.3% of patients with HIV infection and anemic syndrome. In patients with ACD, an increased concentration of erythropoietin is combined with the lowest number of red blood cells in comparison with other groups of patients with anemia (p<0.05). The results obtained indicate a compensatory increase in erythropoietin secretion in response to suppressed erythropoiesis, or to reduced sensitivity of erythropoietin receptors. Further study of the importance of erythropoietin in the pathogenesis of chronic disease in patients with HIV infection is necessary, including to improve its treatment.
- Open Access
- 11 November 2023
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Medicine: theory and practice
- Vol. 8 (4) , 216-229
ON THE QUESTION OF THE MYOCARDIAL INFARCTION CLINICAL COURSE SIGNIFICANCE FOR THE CARDIOGENIC SHOCK DEVELOPMENT IN MALES UNDER 50 YEARS OLD
Введение. Кардиогенный шок характеризуется довольно высокой частотой (6–10%) и остается ведущей причиной ранней смертности при инфаркте миокарда. Цель и задачи. Изучить особенности клинического течения инфаркта миокарда, осложненного кардиогенным шоком, и их роль в развитии этого осложнения у мужчин моложе 50 лет для улучшения профилактики и исходов. Материалы и методы. Изучены результаты стационарного обследования и лечения мужчин 32–49 лет с инфарктом миокарда. Пациенты разделены на двесравнимые по возрасту группы: исследуемую, с кардиогенным шоком — семь пациентов и контрольную, без такового — 223 пациента. Выполнен сравнительный анализ предынфарктного анамнеза ИБС, особенностей клинического течения заболевания и его осложнений в выделенных группах, оценка их влияния (анализ рисков по критерию хи-квадрат Пирсона) на риск развития кардиогенного шока в исследуемой группе. Результаты. При сравнении показателей выявлено преобладание дисфункции почек в исследуемой группе (100%) над контрольной (10,3%; р=0,004), хронической сердечной недостаточности в анамнезе (50,0 и 15,3% соответственно; р=0,04), неангинозных вариантов (абдоминального (16,7 и 1,5%; р=0,0497), аритмического (16,7 и 2,5% р=0,0497) и по типу нарастания сердечной недостаточности (16,7 и 1,5%; р=0,0497)) клинического течения инфаркта миокарда, наличия двух и более осложнений заболевания (100 и 38,1%; р=0,005) с сочетанием всех групп поражений миокарда (57,1 и 6,3%; р ˂0,0001). Риск развития кардиогенного шока увеличивался при диастолическом артериальном давлении ˂70 мм рт.ст. (абсолютный риск: 18,8%; относительный: 13,3; р ˂0,0001), систолическом ˂110 мм рт.ст. (14,3%; 9,9 соответственно; р=0,0004), общем периферическом сопротивлении (37,5%; 35,8 соответственно; р ˂0,0001). Выводы. Перечисленные факторы необходимо использовать при формировании групп высокого риска развития кардиогенного шока при инфаркте миокарда у мужчин моложе 50 лет для наблюдения и своевременного проведения необходимого лечения. Их также целесообразно учитывать при прогностическом моделировании этого осложнения. Background. Cardiogenic shock is characterized by a high frequency (6–10%) and remains the leading cause of early death in myocardial infarction. Purposes and tasks. To evaluate the complicated by cardiogenic shock myocardial infarction clinical course features and their role in this complication development in males under 50 years old (y.o) to improve prevention and outcomes. Materials and methods. The results of inpatient examination and treatment of males aged 32–60 y.o. with MI were studied. Patients were divided into two age-comparable groups: the study group, with cardiogenic shock — 7 patients and the control group, without it — 233 patients. A comparative analysis of the pre-infarction anamnesis of coronary artery disease, the characteristics of the myocardial infarction clinical course and its complications in selected groups, and an assessment of their influence (risk analysis by Pearson’s Chi-square test) on the risk of cardiogenic shock development in the study group were performed. The results. When comparing the indicators, the predominance of kidney dysfunction in the study group (100%) over the control group (10.3%; p=0.004), chronic heart failure in the patient’s medical history (50.0 and 15.3%, respectively; p=0.04), non-anginal variants (abdominal (16.7% and 1.5%; p=0.0497), arrhythmic (16.7 and 2.5% p = 0.0497) and according to the type of increase in heart failure (16.7 and 1.5%; p=0.0497)) of the myocardial infarction clinical course, the presence of two or more disease complications (100 and 38.1%; p=0.005) with a combination of all groups of myocardial lesions (57.1% and 6.3%; p ˂0.0001). The risk of cardiogenic shock development increased with diastolic blood pressure ˂70 mm Hg. (Absolute risk: 18.8%; relative: 13.3; p ˂0.0001), systolic ˂110 mmHg. (14.3%; 9.9, respectively; p=0.0004), total peripheral resistance (37.5%; 35.8, respectively; p ˂0.0001). Conclusions. These factors should be used in the formation of high-risk groups for the cardiogenic shock during myocardial infarction development in males under 50 y.o. for monitoring and timely implementation of the necessary treatment. It is also expedient to take them into account in the prognostic modeling of this complication.
- 11 November 2023
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Medicine: theory and practice
- Vol. 8 (4) , 216-229
Open AccessON THE QUESTION OF THE MYOCARDIAL INFARCTION CLINICAL COURSE SIGNIFICANCE FOR THE CARDIOGENIC SHOCK DEVELOPMENT IN MALES UNDER 50 YEARS OLD
Введение. Кардиогенный шок характеризуется довольно высокой частотой (6–10%) и остается ведущей причиной ранней смертности при инфаркте миокарда. Цель и задачи. Изучить особенности клинического течения инфаркта миокарда, осложненного кардиогенным шоком, и их роль в развитии этого осложнения у мужчин моложе 50 лет для улучшения профилактики и исходов. Материалы и методы. Изучены результаты стационарного обследования и лечения мужчин 32–49 лет с инфарктом миокарда. Пациенты разделены на двесравнимые по возрасту группы: исследуемую, с кардиогенным шоком — семь пациентов и контрольную, без такового — 223 пациента. Выполнен сравнительный анализ предынфарктного анамнеза ИБС, особенностей клинического течения заболевания и его осложнений в выделенных группах, оценка их влияния (анализ рисков по критерию хи-квадрат Пирсона) на риск развития кардиогенного шока в исследуемой группе. Результаты. При сравнении показателей выявлено преобладание дисфункции почек в исследуемой группе (100%) над контрольной (10,3%; р=0,004), хронической сердечной недостаточности в анамнезе (50,0 и 15,3% соответственно; р=0,04), неангинозных вариантов (абдоминального (16,7 и 1,5%; р=0,0497), аритмического (16,7 и 2,5% р=0,0497) и по типу нарастания сердечной недостаточности (16,7 и 1,5%; р=0,0497)) клинического течения инфаркта миокарда, наличия двух и более осложнений заболевания (100 и 38,1%; р=0,005) с сочетанием всех групп поражений миокарда (57,1 и 6,3%; р ˂0,0001). Риск развития кардиогенного шока увеличивался при диастолическом артериальном давлении ˂70 мм рт.ст. (абсолютный риск: 18,8%; относительный: 13,3; р ˂0,0001), систолическом ˂110 мм рт.ст. (14,3%; 9,9 соответственно; р=0,0004), общем периферическом сопротивлении (37,5%; 35,8 соответственно; р ˂0,0001). Выводы. Перечисленные факторы необходимо использовать при формировании групп высокого риска развития кардиогенного шока при инфаркте миокарда у мужчин моложе 50 лет для наблюдения и своевременного проведения необходимого лечения. Их также целесообразно учитывать при прогностическом моделировании этого осложнения. Background. Cardiogenic shock is characterized by a high frequency (6–10%) and remains the leading cause of early death in myocardial infarction. Purposes and tasks. To evaluate the complicated by cardiogenic shock myocardial infarction clinical course features and their role in this complication development in males under 50 years old (y.o) to improve prevention and outcomes. Materials and methods. The results of inpatient examination and treatment of males aged 32–60 y.o. with MI were studied. Patients were divided into two age-comparable groups: the study group, with cardiogenic shock — 7 patients and the control group, without it — 233 patients. A comparative analysis of the pre-infarction anamnesis of coronary artery disease, the characteristics of the myocardial infarction clinical course and its complications in selected groups, and an assessment of their influence (risk analysis by Pearson’s Chi-square test) on the risk of cardiogenic shock development in the study group were performed. The results. When comparing the indicators, the predominance of kidney dysfunction in the study group (100%) over the control group (10.3%; p=0.004), chronic heart failure in the patient’s medical history (50.0 and 15.3%, respectively; p=0.04), non-anginal variants (abdominal (16.7% and 1.5%; p=0.0497), arrhythmic (16.7 and 2.5% p = 0.0497) and according to the type of increase in heart failure (16.7 and 1.5%; p=0.0497)) of the myocardial infarction clinical course, the presence of two or more disease complications (100 and 38.1%; p=0.005) with a combination of all groups of myocardial lesions (57.1% and 6.3%; p ˂0.0001). The risk of cardiogenic shock development increased with diastolic blood pressure ˂70 mm Hg. (Absolute risk: 18.8%; relative: 13.3; p ˂0.0001), systolic ˂110 mmHg. (14.3%; 9.9, respectively; p=0.0004), total peripheral resistance (37.5%; 35.8, respectively; p ˂0.0001). Conclusions. These factors should be used in the formation of high-risk groups for the cardiogenic shock during myocardial infarction development in males under 50 y.o. for monitoring and timely implementation of the necessary treatment. It is also expedient to take them into account in the prognostic modeling of this complication.
- Open Access
- 27 May 2023
- Published by Publishing House ABV Press in Oncohematology
- Vol. 18 (2) , 45‑52
Comparison of cytokine secretion and study of their effect on erythropoiesis in patients with malignant neoplasms with anemia of chronic disease, iron deficiency anemia, and their combination
Aim. To compare the secretion of interleukin-6 (IL-6), interleukin-10 (IL-10) and tumor necrosis factor-alpha (TNF-α) in cancer patients with anemia of chronic disease (ACD), iron deficiency anemia (IDA) and a combination of these two anemia types. To assess the effect of the studied cytokines on erythropoiesis in patients with malignant neoplasms separately for each type of anemia studied.Materials and methods. 106 patients with stage II–IV of solid malignant neoplasms were examined: 84 with anemia (55 men, 29 women, 67.1 ± 9.9 years), 22 without anemia (17 men, 5 women, mean age 60.2 ± 14.9 years). In accordance with Van Santen and Worwood criteria, by determining the transferrin saturation coefficient, ferritin concentrations, C-reactive protein, patients were divided into 4 groups: group 1 – patients with ACD, 31 (20 / 11 patients), 2 group – ACD / IDA, 28 (18 / 10 patients), group 3 – IDA, 25 (17 / 8 patients), group 4 (control) – 22 patients without anemia. In all patients, the number of erythrocytes, the concentration of hemoglobin, ferritin, C-reactive protein, transferrin saturation coefficient, IL-6, TNF-α, IL-10 were determined. For quantitative indicators, the arithmetic mean and interquartile range (IQR) were calculated. Significance of differences between several unrelated groups was determined using the Kruskal–Wallis test. To assess the relationship between variables, the Spearman correlation coefficient (r) was calculated.Results. In the ACD group, the maximum IL-6 concentration was 73.3 (IQR 6.2–51), TNF-α – 24.4 (IQR 15.3–60.7) and IL-10 – 8.7 (IQR 4.7–12.1) compared with the ACH3 / IDA group (IL-6 – 9.3 [IQR 4.4–13.2], TNF-α – 7.2 [IQR 4.5–9.6] and IL-10 – 6.7 [IQR 4.1–11.4]), and the IDA group (IL-6 – 3.4 [IQR 1.4–5.9], TNF-α – 4.6 [IQR 3.7–6] and IL-10 – 2.5 [IQR 0–5]) (p 0.05). In the ACD group, the highest correlation coefficients were found between IL-6 and erythrocytes (r = –0.74) and hemoglobin (r = –0.88), between TNF-α and erythrocytes (r = –0.66) and hemoglobin (r = –0.77), between IL-10 and erythrocytes (r = –0.36) and hemoglobin (r = –0.63). In the IDA group, the correlation coefficients between cytokines, erythrocytes, and hemoglobin are low or absent.Conclusion. In cancer patients, ACD, IDA, as well as their combination can occur. Increased cytokine secretion in ACD group patients is important due to the proven strong negative effect of cytokines on erythropoiesis. Further study of ACD pathogenesis is needed in order to improve treatment.
- 27 May 2023
- Published by Publishing House ABV Press in Oncohematology
- Vol. 18 (2) , 45‑52
Open AccessComparison of cytokine secretion and study of their effect on erythropoiesis in patients with malignant neoplasms with anemia of chronic disease, iron deficiency anemia, and their combination
Aim. To compare the secretion of interleukin-6 (IL-6), interleukin-10 (IL-10) and tumor necrosis factor-alpha (TNF-α) in cancer patients with anemia of chronic disease (ACD), iron deficiency anemia (IDA) and a combination of these two anemia types. To assess the effect of the studied cytokines on erythropoiesis in patients with malignant neoplasms separately for each type of anemia studied.Materials and methods. 106 patients with stage II–IV of solid malignant neoplasms were examined: 84 with anemia (55 men, 29 women, 67.1 ± 9.9 years), 22 without anemia (17 men, 5 women, mean age 60.2 ± 14.9 years). In accordance with Van Santen and Worwood criteria, by determining the transferrin saturation coefficient, ferritin concentrations, C-reactive protein, patients were divided into 4 groups: group 1 – patients with ACD, 31 (20 / 11 patients), 2 group – ACD / IDA, 28 (18 / 10 patients), group 3 – IDA, 25 (17 / 8 patients), group 4 (control) – 22 patients without anemia. In all patients, the number of erythrocytes, the concentration of hemoglobin, ferritin, C-reactive protein, transferrin saturation coefficient, IL-6, TNF-α, IL-10 were determined. For quantitative indicators, the arithmetic mean and interquartile range (IQR) were calculated. Significance of differences between several unrelated groups was determined using the Kruskal–Wallis test. To assess the relationship between variables, the Spearman correlation coefficient (r) was calculated.Results. In the ACD group, the maximum IL-6 concentration was 73.3 (IQR 6.2–51), TNF-α – 24.4 (IQR 15.3–60.7) and IL-10 – 8.7 (IQR 4.7–12.1) compared with the ACH3 / IDA group (IL-6 – 9.3 [IQR 4.4–13.2], TNF-α – 7.2 [IQR 4.5–9.6] and IL-10 – 6.7 [IQR 4.1–11.4]), and the IDA group (IL-6 – 3.4 [IQR 1.4–5.9], TNF-α – 4.6 [IQR 3.7–6] and IL-10 – 2.5 [IQR 0–5]) (p 0.05). In the ACD group, the highest correlation coefficients were found between IL-6 and erythrocytes (r = –0.74) and hemoglobin (r = –0.88), between TNF-α and erythrocytes (r = –0.66) and hemoglobin (r = –0.77), between IL-10 and erythrocytes (r = –0.36) and hemoglobin (r = –0.63). In the IDA group, the correlation coefficients between cytokines, erythrocytes, and hemoglobin are low or absent.Conclusion. In cancer patients, ACD, IDA, as well as their combination can occur. Increased cytokine secretion in ACD group patients is important due to the proven strong negative effect of cytokines on erythropoiesis. Further study of ACD pathogenesis is needed in order to improve treatment.
- 25 February 2023
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
COMPARATIVE ANALYSIS OF THE SECRETION OF INTERLEUKIN-6, INTERLEUKIN-1BETA, INTERLEUKIN-10, TUMOR NECROSIS FACTOR-ALPHA, INTERFERON-GAMMA IN VARIOUS TYPES OF ANEMIA IN PATIENTS WITH HIV INFECTION
Aim. To compare the secretion of interleukin-6 (IL-6), interleukin-10 (IL-10), interleukin-1-beta, tumor necrosis factor-alpha (TNF-α), interferon-gamma (INF-γ) in patients with HIV infection with anemia of chronic disease (ACD), iron deficiency anemia (IDA), as well as their combination. To assess the effect of the studied cytokines on erythropoiesis in each of the studied types of anemia in this category of patients. Material and methods. 125 patients with HIV infection were examined: 101 with anemia (55 men, 46 women, 39.4±9.6 years), 24 patients with HIV infection without anemia (13 men, 11 women, mean age 37.6± 7.37 years). In accordance with the Van Santen and Worwood criteria, by determining the transferrin saturation index (TSI), ferritin concentrations, C-reactive protein (CRP), patients with anemia were divided into 3 groups: group 1 – 36 patients with ACD (19 men, 17 women, mean age 41.7±11.8 years), group 2 – 30 patients with a combination of ACD/IDA (18 men, 12 women, mean age 41.2±10 years), group 3 – 35 patients with IDA (18 men, 17 women, mean age 35.4±7.1 years). In all patients, the number of erythrocytes, the concentration of hemoglobin, ferritin, CRP, CNT, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), interleukin-10 (IL-10), interleukin-1beta (IL-1β), interferon-gamma (INF-γ). For quantitative indicators, the arithmetic mean, standard error of the mean, and interquartile range (IQR) were calculated. Significance of differences between several unrelated groups was determined using the Kruskal-Wallis’s test. To assess the relationship between variables, the Spearman correlation coefficient I was calculated. Results. In the ACD group, the maximum concentration of IL-6 (36.6 [IQR, 11.5-51.1]) and IL-10 (21.6 [IQR, 11.4-28.8]) compared with the ACD/IDA group (IL-6 (9.1 [IQR, 5.1-11.4]), IL-10 (15.5 [IQR, (7.1-21.6)]), and IDA (IL- 6 (6.2 [IQR, 1.6–7.2]), IL-10 (8.6 [IQR, 3.9–9.3]) (p<0.05). In the groups of patients with ACD and ACD/IDA, the maximum and almost equal concentrations of TNF-α (15.2 [IQR,6.1-24.1] in the ACD group and 17.3[IQR,7.9-17.3] in the ACD/IDA group), IL-1β (16.7[IQR,4.7-28.9] in the ACD group and 19.2 [IQR,3.9-28.8] in the ACD/IDA group), INF-γ ( 62.6[IQR,4.6-85.3] in the ACD group and 58.3[IQR,8.5-37.5] in the ACD/IDA group), which were statistically significantly higher than the concentrations of these cytokines in patients with IDA and the control group. There were no significant differences in the concentrations of TNF-α, IL-1β, IL-10 and IFN-γ between patients with IDA and the control group. Significant moderate and strong negative correlations were found in the groups of patients with ACD and ACD/IDA between all studied cytokines, erythrocytes and hemoglobin. In the IDA group, the correlation coefficients between cytokines, erythrocytes, and hemoglobin are low or absent. Conclusions. In patients with HIV infection, a wide prevalence of ACD has been shown, especially in patients with immunodeficiency and in the late stages of the disease. ACD, unlike IDA, has a complex multicomponent pathogenesis. This study shows the importance of pro-inflammatory and inflammatory cytokines in the development of ACD in HIV patients, including due to their negative effect on erythropoiesis and hemoglobin synthesis. A working version of the classification of ACD (with a predominant iron deficiency, with impaired regulatory mechanisms of erythropoiesis, with insufficient production of erythropoietin) has been proposed. It is necessary to further study the pathogenesis of ACD in this category of patients to improve treatment.
- 25 February 2023
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
COMPARATIVE ANALYSIS OF THE SECRETION OF INTERLEUKIN-6, INTERLEUKIN-1BETA, INTERLEUKIN-10, TUMOR NECROSIS FACTOR-ALPHA, INTERFERON-GAMMA IN VARIOUS TYPES OF ANEMIA IN PATIENTS WITH HIV INFECTION
Aim. To compare the secretion of interleukin-6 (IL-6), interleukin-10 (IL-10), interleukin-1-beta, tumor necrosis factor-alpha (TNF-α), interferon-gamma (INF-γ) in patients with HIV infection with anemia of chronic disease (ACD), iron deficiency anemia (IDA), as well as their combination. To assess the effect of the studied cytokines on erythropoiesis in each of the studied types of anemia in this category of patients. Material and methods. 125 patients with HIV infection were examined: 101 with anemia (55 men, 46 women, 39.4±9.6 years), 24 patients with HIV infection without anemia (13 men, 11 women, mean age 37.6± 7.37 years). In accordance with the Van Santen and Worwood criteria, by determining the transferrin saturation index (TSI), ferritin concentrations, C-reactive protein (CRP), patients with anemia were divided into 3 groups: group 1 – 36 patients with ACD (19 men, 17 women, mean age 41.7±11.8 years), group 2 – 30 patients with a combination of ACD/IDA (18 men, 12 women, mean age 41.2±10 years), group 3 – 35 patients with IDA (18 men, 17 women, mean age 35.4±7.1 years). In all patients, the number of erythrocytes, the concentration of hemoglobin, ferritin, CRP, CNT, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), interleukin-10 (IL-10), interleukin-1beta (IL-1β), interferon-gamma (INF-γ). For quantitative indicators, the arithmetic mean, standard error of the mean, and interquartile range (IQR) were calculated. Significance of differences between several unrelated groups was determined using the Kruskal-Wallis’s test. To assess the relationship between variables, the Spearman correlation coefficient I was calculated. Results. In the ACD group, the maximum concentration of IL-6 (36.6 [IQR, 11.5-51.1]) and IL-10 (21.6 [IQR, 11.4-28.8]) compared with the ACD/IDA group (IL-6 (9.1 [IQR, 5.1-11.4]), IL-10 (15.5 [IQR, (7.1-21.6)]), and IDA (IL- 6 (6.2 [IQR, 1.6–7.2]), IL-10 (8.6 [IQR, 3.9–9.3]) (p<0.05). In the groups of patients with ACD and ACD/IDA, the maximum and almost equal concentrations of TNF-α (15.2 [IQR,6.1-24.1] in the ACD group and 17.3[IQR,7.9-17.3] in the ACD/IDA group), IL-1β (16.7[IQR,4.7-28.9] in the ACD group and 19.2 [IQR,3.9-28.8] in the ACD/IDA group), INF-γ ( 62.6[IQR,4.6-85.3] in the ACD group and 58.3[IQR,8.5-37.5] in the ACD/IDA group), which were statistically significantly higher than the concentrations of these cytokines in patients with IDA and the control group. There were no significant differences in the concentrations of TNF-α, IL-1β, IL-10 and IFN-γ between patients with IDA and the control group. Significant moderate and strong negative correlations were found in the groups of patients with ACD and ACD/IDA between all studied cytokines, erythrocytes and hemoglobin. In the IDA group, the correlation coefficients between cytokines, erythrocytes, and hemoglobin are low or absent. Conclusions. In patients with HIV infection, a wide prevalence of ACD has been shown, especially in patients with immunodeficiency and in the late stages of the disease. ACD, unlike IDA, has a complex multicomponent pathogenesis. This study shows the importance of pro-inflammatory and inflammatory cytokines in the development of ACD in HIV patients, including due to their negative effect on erythropoiesis and hemoglobin synthesis. A working version of the classification of ACD (with a predominant iron deficiency, with impaired regulatory mechanisms of erythropoiesis, with insufficient production of erythropoietin) has been proposed. It is necessary to further study the pathogenesis of ACD in this category of patients to improve treatment.
- 30 November 2022
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
CHANGES IN LIPID METABOLISM DURING THE INITIAL PERIODS MYOCARDIAL INFARCTION COMPLICATED BY ACUTE KIDNEY INJURY IN YOUNG AND MIDDLE-AGED MEN
Relevance. Changes in lipid metabolism during myocardial infarction (MI) complicated by acute kidney injury (AKI) are potentially important for evaluating the effects of therapy and expanding the possibilities of prevention. Aim. To evaluate the changes in lipid metabolism during acute and subacute MI periods and their role in the complication’s development in men under 60 years old (y.o.) with AKI to im-prove prevention and outcomes. Material and methods. The results of inpatient examination and treatment of men aged 20-60 y.o. with MI were studied. Patients were divided into two age-comparable groups: the study group, with AKI - 22 patients and the control group, without it - 141 patients. The parameters of lipid metabolism and their dynamics were compared in the first hours (1) and at the end of the third week of MI (2) in selected groups, their influence was assessed (risk analysis by Pearson's Chi-square test) on the risk of AKI development and complications MI in the study group. Results. In the study group, the following were observed: higher levels of low-density lipo-protein2 (LDL2) (5.53±2.50 mmol/l) compared to the control group (3.33±2.45 mmol/l; p=0.02); an increase in the levels of very low-density lipoproteins, a coefficient and an atherogenic index, a decrease in triglycerides (TG) at the end of the third week of the disease. The risk of AKI development was associated with the concentration of TG1≥1.88 mmol/l (p=0.007). Complicated course of MI in the study group is characterized by levels of LDL1≥4.0 (p=0.02), high-density lipoprotein1 (HDL1)˂1.1 (mmol/l; p=0.02), and their ratio (LDL1/HDL1) ≥4.5 (p =0.02). Conclusions. In AKI, persistent atherogenic changes in lipids are noted both in the acute and at the end of the subacute period of MI. The risk of developing AKI increases at levels of TG1≥1.88 mmol/l, and the complicated course of MI in the study group is associated with lev-els of LDL1≥4.0, HDL1˂1.1 (mmol/l) and LDL1/HDL1≥4.5. It is expedient to use them in predictive modeling.
- 30 November 2022
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
CHANGES IN LIPID METABOLISM DURING THE INITIAL PERIODS MYOCARDIAL INFARCTION COMPLICATED BY ACUTE KIDNEY INJURY IN YOUNG AND MIDDLE-AGED MEN
Relevance. Changes in lipid metabolism during myocardial infarction (MI) complicated by acute kidney injury (AKI) are potentially important for evaluating the effects of therapy and expanding the possibilities of prevention. Aim. To evaluate the changes in lipid metabolism during acute and subacute MI periods and their role in the complication’s development in men under 60 years old (y.o.) with AKI to im-prove prevention and outcomes. Material and methods. The results of inpatient examination and treatment of men aged 20-60 y.o. with MI were studied. Patients were divided into two age-comparable groups: the study group, with AKI - 22 patients and the control group, without it - 141 patients. The parameters of lipid metabolism and their dynamics were compared in the first hours (1) and at the end of the third week of MI (2) in selected groups, their influence was assessed (risk analysis by Pearson's Chi-square test) on the risk of AKI development and complications MI in the study group. Results. In the study group, the following were observed: higher levels of low-density lipo-protein2 (LDL2) (5.53±2.50 mmol/l) compared to the control group (3.33±2.45 mmol/l; p=0.02); an increase in the levels of very low-density lipoproteins, a coefficient and an atherogenic index, a decrease in triglycerides (TG) at the end of the third week of the disease. The risk of AKI development was associated with the concentration of TG1≥1.88 mmol/l (p=0.007). Complicated course of MI in the study group is characterized by levels of LDL1≥4.0 (p=0.02), high-density lipoprotein1 (HDL1)˂1.1 (mmol/l; p=0.02), and their ratio (LDL1/HDL1) ≥4.5 (p =0.02). Conclusions. In AKI, persistent atherogenic changes in lipids are noted both in the acute and at the end of the subacute period of MI. The risk of developing AKI increases at levels of TG1≥1.88 mmol/l, and the complicated course of MI in the study group is associated with lev-els of LDL1≥4.0, HDL1˂1.1 (mmol/l) and LDL1/HDL1≥4.5. It is expedient to use them in predictive modeling.
- 15 September 2022
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
ACUTE KIDNEY INJURY RISK FACTORS DEVELOPMENT DURING MYOCARDIAL INFARCTION IN YOUNG AND MIDDLE-AGE MEN WITH GOUT
Relevance. Acute kidney injury (AKI) in myocardial infarction worsens the prognosis and increases the duration of treatment of patients. Aim. To evaluate predictors of acute kidney injury in myocardial infarction in men younger than 60 years of age with gout to assess opportunities to improve prevention. Material and methods. The study included men 42-59 years old (y.o.) with type I MI and gout. Patients were divided into two age-comparable groups: I - study group, with AKI - two pa-tients; II - control, without it - 24 patients. Comparative evaluation of data on cardiovascular risk factors, parameters of the disease course in selected groups was performed. Quantitative parameters were determined twice, in the first 48 hours (1) and at the end of the third week (2) of MI. Pearson's chi-square method was used to assess the absolute (AR) and relative (RR) risks of developing AKI under the influence of the listed factors. Results. A significant effect on the possibility of developing AKI in the examined patients was obtained for: a history of urolithiasis (AR 50.0%; p=0.01), MI in the winter period (AR 40.0%; p=0.03 ); levels of low-density lipoproteins1<2.5 mmol/l (AR 50.0%; p=0.04), ratios of total cholesterol1/high-density lipoproteins1<3.7 (AR 50.0%; p=0.04), glucose1 ≥8.9 mmol/l (AR 100.0%; RR 14.0; p=0.008); potassium1 ˂3.8 mmol/l (AR 100.0%; RR 13.0; p=0.01), glomerular filtration rate (СKD-EPI)1≥123.0 ml/min/1.73 m2 (AR 100.0%; RR 14.0, p=0.008); polytopic extrasystole (AR 100.0%; RR 14.0; p=0.008), thromboembolism (AR 100.0%; RR 14.0; p=0.08) in the structure of MI complications; levels of systolic blood pres-sure (BPsyst)1≥200 mm Hg. (AR 66.7%; p=0.002), mean BP1≥133.0 (AR 66.7%; p=0.002), stroke index1≥39.8 ml/m2 (AR 66.7%; p=0.002), transverse dimension of the right atrium (RA)1 ˃52 mm (AR 50.0%; p=0.01). Conclusions. The most important for the risk of AKI development during MI in men under 60 y.o. with gout were arterial hypertension (BPsyst≥200 mHg), hyperglycemia (≥8.9 mmol/l), RA dilation (˃52 mm), history of urolithiasis. Combinations of the above parameters should be used to form high-risk groups for AKI development in this category of patients to improve preventive measures, as well as for predictive modeling.
- 15 September 2022
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
ACUTE KIDNEY INJURY RISK FACTORS DEVELOPMENT DURING MYOCARDIAL INFARCTION IN YOUNG AND MIDDLE-AGE MEN WITH GOUT
Relevance. Acute kidney injury (AKI) in myocardial infarction worsens the prognosis and increases the duration of treatment of patients. Aim. To evaluate predictors of acute kidney injury in myocardial infarction in men younger than 60 years of age with gout to assess opportunities to improve prevention. Material and methods. The study included men 42-59 years old (y.o.) with type I MI and gout. Patients were divided into two age-comparable groups: I - study group, with AKI - two pa-tients; II - control, without it - 24 patients. Comparative evaluation of data on cardiovascular risk factors, parameters of the disease course in selected groups was performed. Quantitative parameters were determined twice, in the first 48 hours (1) and at the end of the third week (2) of MI. Pearson's chi-square method was used to assess the absolute (AR) and relative (RR) risks of developing AKI under the influence of the listed factors. Results. A significant effect on the possibility of developing AKI in the examined patients was obtained for: a history of urolithiasis (AR 50.0%; p=0.01), MI in the winter period (AR 40.0%; p=0.03 ); levels of low-density lipoproteins1<2.5 mmol/l (AR 50.0%; p=0.04), ratios of total cholesterol1/high-density lipoproteins1<3.7 (AR 50.0%; p=0.04), glucose1 ≥8.9 mmol/l (AR 100.0%; RR 14.0; p=0.008); potassium1 ˂3.8 mmol/l (AR 100.0%; RR 13.0; p=0.01), glomerular filtration rate (СKD-EPI)1≥123.0 ml/min/1.73 m2 (AR 100.0%; RR 14.0, p=0.008); polytopic extrasystole (AR 100.0%; RR 14.0; p=0.008), thromboembolism (AR 100.0%; RR 14.0; p=0.08) in the structure of MI complications; levels of systolic blood pres-sure (BPsyst)1≥200 mm Hg. (AR 66.7%; p=0.002), mean BP1≥133.0 (AR 66.7%; p=0.002), stroke index1≥39.8 ml/m2 (AR 66.7%; p=0.002), transverse dimension of the right atrium (RA)1 ˃52 mm (AR 50.0%; p=0.01). Conclusions. The most important for the risk of AKI development during MI in men under 60 y.o. with gout were arterial hypertension (BPsyst≥200 mHg), hyperglycemia (≥8.9 mmol/l), RA dilation (˃52 mm), history of urolithiasis. Combinations of the above parameters should be used to form high-risk groups for AKI development in this category of patients to improve preventive measures, as well as for predictive modeling.